Cargando…

Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy

Detalles Bibliográficos
Autores principales: Shi, Chen, Jian, Chen, Wang, Lulu, Gao, Chen, Yang, Ting, Fu, Zhiwen, Wu, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662553/
https://www.ncbi.nlm.nih.gov/pubmed/37985998
http://dx.doi.org/10.1186/s12951-023-02140-6
_version_ 1785148561176920064
author Shi, Chen
Jian, Chen
Wang, Lulu
Gao, Chen
Yang, Ting
Fu, Zhiwen
Wu, Tingting
author_facet Shi, Chen
Jian, Chen
Wang, Lulu
Gao, Chen
Yang, Ting
Fu, Zhiwen
Wu, Tingting
author_sort Shi, Chen
collection PubMed
description
format Online
Article
Text
id pubmed-10662553
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106625532023-11-21 Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy Shi, Chen Jian, Chen Wang, Lulu Gao, Chen Yang, Ting Fu, Zhiwen Wu, Tingting J Nanobiotechnology Correction BioMed Central 2023-11-21 /pmc/articles/PMC10662553/ /pubmed/37985998 http://dx.doi.org/10.1186/s12951-023-02140-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Shi, Chen
Jian, Chen
Wang, Lulu
Gao, Chen
Yang, Ting
Fu, Zhiwen
Wu, Tingting
Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
title Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
title_full Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
title_fullStr Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
title_full_unstemmed Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
title_short Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
title_sort correction: dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662553/
https://www.ncbi.nlm.nih.gov/pubmed/37985998
http://dx.doi.org/10.1186/s12951-023-02140-6
work_keys_str_mv AT shichen correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy
AT jianchen correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy
AT wanglulu correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy
AT gaochen correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy
AT yangting correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy
AT fuzhiwen correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy
AT wutingting correctiondendriticcellhybridnanovaccineformildheatinspiredcancerimmunotherapy